Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DGAP-DD: Fresenius Medical Care AG & Co. KGaA english

05/26/2021 | 11:06am EDT
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons 
closely associated with them 
26.05.2021 / 17:04 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
1. Details of the person discharging managerial responsibilities / person closely associated 
a) Name 
 
 
 Title:         Dr. 
 
 First name:    Olaf 
 
 Last name(s):  Schermeier 
 2. Reason for the notification a) Position / status 
 
 
 Position:     Member of the managing body 
 b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name 
 
 
 Fresenius Medical Care AG & Co. KGaA 
 b) LEI 
 
 
 549300CP8NY40UP89Q40 
 4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code 
 
 
 Type:          Share 
 
 ISIN:          DE0005785802 
 b) Nature of the transaction 
 
 
 Exercise of stock options on Fresenius Medical Care shares of the stock option plan and sale of the shares (cash 
 settlement) 
 
 Transaction linked to the exercise of share option programmes 
 c) Price(s) and volume(s) 
 
 
 Price(s)       Volume(s) 
 
 66.40 EUR      21115.20 EUR 
 
 66.36 EUR      21766.08 EUR 
 
 66.34 EUR      19769.32 EUR 
 
 66.30 EUR      22873.50 EUR 
 
 66.30 EUR      39514.80 EUR 
 
 66.34 EUR      20300.04 EUR 
 
 66.36 EUR      20770.68 EUR 
 
 66.38 EUR      796.56 EUR 
 
 66.38 EUR      5244.02 EUR 
 
 66.38 EUR      11682.88 EUR 
 
 66.40 EUR      16799.20 EUR 
 
 66.40 EUR      1859.20 EUR 
 
 66.40 EUR      17396.80 EUR 
 
 66.40 EUR      1593.60 EUR 
 
 66.42 EUR      20125.26 EUR 
 
 66.42 EUR      996.30 EUR 
 
 66.42 EUR      17402.04 EUR 
 
 66.36 EUR      28203.00 EUR 
 
 66.38 EUR      16063.96 EUR 
 
 66.38 EUR      1792.26 EUR 
 
 66.38 EUR      4181.94 EUR 
 
 66.38 EUR      7965.60 EUR 
 
 66.34 EUR      4577.46 EUR 
 
 66.30 EUR      17768.40 EUR 
 
 66.30 EUR      29768.70 EUR 
 
 66.30 EUR      20553.00 EUR 
 
 66.30 EUR      25459.20 EUR 
 
 66.32 EUR      928.48 EUR 
 
 66.32 EUR      22615.12 EUR 
 
 66.32 EUR      5570.88 EUR 
 
 66.32 EUR      14988.32 EUR 
 
 66.32 EUR      4244.48 EUR 
 
 66.32 EUR      2122.24 EUR 
 
 66.32 EUR      14988.32 EUR 
 
 66.26 EUR      29684.48 EUR 
 
 66.28 EUR      17763.04 EUR 
 
 66.26 EUR      4836.98 EUR 
 
 66.26 EUR      15306.06 EUR 
 
 66.28 EUR      28699.24 EUR 
 
 66.24 EUR      10002.24 EUR 
 
 66.24 EUR      1258.56 EUR 
 
 66.24 EUR      6292.80 EUR 
 
 66.24 EUR      11724.48 EUR 
 
 66.22 EUR      11985.82 EUR 
 d) Aggregated information 
 
 
 Price         Aggregated volume 
 
 66.33 EUR     619350.54 EUR 
 e) Date of the transaction 
 
 
 2021-05-25; UTC+2 
 f) Place of the transaction 
 
 
 Name:          XETRA 
 
 MIC:           XETR 
 ----------------------------------------------------------------------------------------------------------------------- 

26.05.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      Fresenius Medical Care AG & Co. KGaA 
              Else-Kröner-Straße 1 
              61352 Bad Homburg 
              Germany 
Internet:     www.freseniusmedicalcare.com 
 
End of News   DGAP News Service 
=------------ 

67640 26.05.2021

(END) Dow Jones Newswires

May 26, 2021 11:05 ET (15:05 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL 0.78% 35064.25 Delayed Quote.14.74%
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.27% 67.34 Delayed Quote.-1.00%
FRESENIUS SE & CO. KGAA -1.37% 44.765 Delayed Quote.19.94%
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
02:27aFMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Sell rating from Jefferies
MD
08/04DGAP-DD : Fresenius SE & Co. KGaA english
DJ
08/04FMC FRESENIUS MEDICAL CARE AG & CO K : NorldLB maintains a Buy rating
MD
08/04FRESENIUS MEDICAL CARE : uses virtual reality technology to train patients for h..
PU
08/03European ADRs Move Higher in Tuesday Trading
MT
08/02European ADRs Move Higher in Monday Trading
MT
08/02FRESENIUS MEDICAL CARE : RBC Raises Price Target on Fresenius Medical Care to $4..
MT
08/02FRESENIUS : Lifts FY21 Group Earnings Outlook After 'Very Strong' H1
MT
07/30ADRs End Lower; IAG, Fresenius Among Companies Actively Trading
DJ
07/30DGAP-CMS : Fresenius Medical Care AG & Co. KGaA: Release according to Article 50..
DJ
More news
Financials (USD)
Sales 2021 21 230 M - -
Net income 2021 1 246 M - -
Net Debt 2021 13 335 M - -
P/E ratio 2021 15,8x
Yield 2021 2,07%
Capitalization 19 729 M 23 362 M -
EV / Sales 2021 1,56x
EV / Sales 2022 1,46x
Nbr of Employees 123 538
Free-Float 67,8%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | FME | DE0005785802 | MarketScreener
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 67,34 $
Average target price 83,04 $
Spread / Average Target 23,3%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer